0.12
8.75%
-0.0115
22nd Century Group, Inc. stock is currently priced at $0.12, with a 24-hour trading volume of 3.45M.
It has seen a -8.75% decreased in the last 24 hours and a -14.35% declined in the past month.
The chart indicates a potential bearish trend, as the stock is below the $0.1348 pivot point. If it approaches the $0.1167 support level, significant changes may occur.
22nd Century Group, Inc. Stock (XXII) Financials Data
22nd Century Group, Inc. (XXII) Revenue 2023
XXII reported a revenue (TTM) of $82.41 million for the quarter ending September 30, 2023, a +62.01% rise year-over-year.
22nd Century Group, Inc. (XXII) Net Income 2023
XXII net income (TTM) was -$137.72 million for the quarter ending September 30, 2023, a -190.05% decrease year-over-year.
22nd Century Group, Inc. (XXII) Cash Flow 2023
XXII recorded a free cash flow (TTM) of -$75.17 million for the quarter ending September 30, 2023, a -85.43% decrease year-over-year.
22nd Century Group, Inc. (XXII) Earnings per Share 2023
XXII earnings per share (TTM) was -$8.08 for the quarter ending September 30, 2023, a -102.51% decline year-over-year.
22nd Century Group, Inc. Stock (XXII) Latest News
Why Kodiak Sciences Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Benzinga
Why RH Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
Benzinga
Zacks Industry Outlook Highlights Philip Morris International, Altria and 22nd Century Group
Zacks Investment Research
3 Tobacco Stocks Grabbing Attention on Solid Industry Trends
Zacks Investment Research
OPKO Health And 3 Other Stocks Under $5 Insiders Are Buying
Benzinga
22nd Century Group And 2 Other Stocks Under $2 Insiders Are Buying
Benzinga
About 22nd Century Group, Inc.
22nd Century Group, Inc., a plant biotechnology company, provides technology that allows increasing or decreasing the level of nicotine and other nicotinic alkaloids in tobacco plants, and cannabinoids in hemp/cannabis plants through genetic engineering and plant breeding. It offers premium cigarettes under the RED SUN and MAGIC brands; and SPECTRUM, a line of research cigarettes for use in independent clinical studies. The company's products under development include BRAND A, a very low nicotine cigarette; X-22, a tobacco-based botanical medical product for use as an aid to smoking cessation; and BRAND B, a low-tar-to-nicotine ratio cigarette. In addition, it engages in contract manufacturing business for third-party branded tobacco products. The company has scientific collaborations with the University of Virginia and Anandia Laboratories, Inc. to develop proprietary hemp strains with less than 0.3% dry weight content of delta-9-tetrahydrocannabinol. 22nd Century Group, Inc. was founded in 1998 and is headquartered in Williamsville, New York.
Cap:
|
Volume (24h):